About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Hypertension Clinical Trials in Houston | 372 Studies

Clinical Trials HypertensionHouston

Hypertension Clinical Trials in Houston

Find 372 clinical trials for hypertension near Houston, Texas. Connect with research centers in your area.

All Hypertension trials nationwide All trials in Houston

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 121-140 of 372 trials

TerminatedPost Approval Study of the CyPass SystemThe purpose of this study is to demonstrate that the rate of clinically relevant complications associated with CyPass Micro-Stent placement and stability using the CyPass 241-S…NCT03273907·Phoenix, Arizona and 19 others CompletedThe Efficacy and Safety of Sildenafil Citrate Used in Combination With Intravenous Epoprostenol in PAHDetermination of the effects of sildenafil citrate and epoprostenol when used in combination in patients with pulmonary arterial hypertensionNCT00159861·La Jolla, California and 51 others

Hypertension Trials in Other Cities

New York Los Angeles Chicago Phoenix Philadelphia San Antonio

Data from ClinicalTrials.govTerms

CompletedBREATHE 5-OL: Tracleer (Bosentan) in Patients With Pulmonary Arterial Hypertension Related to Eisenmenger PhysiologyThis 6-month open label study will evaluate the long term safety of bosentan (via oxygen saturation) and efficacy (exercise capacity) in patients who have completed the BREATHE-5…NCT00367770·Boston, Massachusetts and 16 others

Active not recruitingADAPT - A Patient Registry of the Real-world Use of Orenitram®This prospective, observational, multicenter, patient registry will follow patients who are receiving treatment with Orenitram for the treatment of PAH for up to 78 weeks from…NCT03045029·Fresno, California and 40 others

No longer availableRiociguat in Patients With Chronic Thromboembolic Pulmonary Hypertension (CTEPH)The aim of the study is to assess safety, tolerability and clinical effects of different doses of riociguat in patients with inoperable Chronic Thromboembolic Pulmonary…NCT01784562·Tucson, Arizona and 101 others

Completed307B - Safety, Tolerability and Pharmacokinetics Study of TOPROL-XL® in Hypertensive Pediatric SubjectsThis was a 52-week, multicenter, open-label study to determine the safety, tolerability and pharmacokinetics of TOPROL-XL (metoprolol succinate) extended-release tablets…NCT00255502·Little Rock, Arkansas and 30 others

TerminatedSitaxsentan Efficacy And Safety Trial With A Randomized Prospective Assessment Of Adding Sildenafil (SR-PAAS)This protocol is for subjects with pulmonary arterial hypertension and is the first of 3 studies forming the Sitaxsentan efficacy and safety trial with Randomized Prospective…NCT00795639·Fountain Valley, California and 84 others

CompletedClinical Study to Assess the Long-term Safety and Tolerability of ACT 064992 in Patients With Symptomatic Pulmonary Arterial HypertensionThe main objective of the AC 055 303/SERAPHIN OL study, which will follow the AC 055 302/SERAPHIN study, will be to assess the long-term safety and tolerability of ACT 064992 in…NCT00667823·Birmingham, Alabama and 157 others

CompletedBeraprost-314d Added-on to Tyvaso® (BEAT)This is a multicenter, double-blind, randomized, placebo-controlled Phase 3 study, to assess the efficacy and safety of BPS-314d-MR when added-on to inhaled treprostinil…NCT01908699·Birmingham, Alabama and 74 others

CompletedPerinatal Outcomes Following Change in Clinical Criteria in for Treatment of Maternal HypertensionThe purpose of this study is observe outcomes before and after a change in clinical practice in the threshold for management of severe hypertension in pregnancy and the…NCT05881252·Houston, Texas

CompletedEfficacy and Safety of Azilsartan Medoxomil Co-Administered With Chlorthalidone in Participants With Essential HypertensionThe purpose of this study is to evaluate the efficacy and safety of azilsartan medoxomil, once daily (QD), co-administered with chlorthalidone in treating individuals with…NCT00591773·Huntsville, Alabama and 45 others

CompletedAccuracy Assessment of an Automatic Blood Pressure Measurement Device in Pregnant WomenThe purpose of the study is to help make a lower cost automatic blood pressure monitor device for diagnosis and monitoring of pre-eclampsia in pregnant women, where automatic…NCT02319174·Houston, Texas

Not yet recruitingMH-Rx Study (Baby on Board: Check-in on You, Your Medication, & Your Blood Pressure)This randomized controlled trial will evaluate whether adding Community Health Worker (CHW)/Social Worker (SW)-led support for non-medical health related needs (NMHRN) and…NCT07842341·Houston, Texas

RecruitingNon-Invasive Preeclampsia Screening and BiobankWomen pregnant between 11-14 weeks gestation will be enrolled with blood samples collected to evaluate for preeclampsia.NCT06643741·Glendale, Arizona and 20 others

CompletedStudy of Co-administration of Olmesartan Medoxomil Plus Amlodipine in Patients With Mild to Severe HypertensionThis study assesses the efficacy and safety of co-administration of olmesartan medoxomil plus amlodipine in mild to severe hypertensive patients older than 18 years of ageNCT00185133·Birmingham, Alabama and 138 others

CompletedEffect of Intense vs. Standard Hypertension Management on Nighttime Blood Pressure - an Ancillary Study to SPRINTHypertension is a major risk factor for cardiovascular and renal disease, and a leading cause of premature mortality worldwide.NCT01835249·Birmingham, Alabama and 9 others

RecruitingA Study to Evaluate Efficacy and Safety of YSBP Compared to Lumigan in Patients With Glaucoma or Ocular HypertensionThis study is to establish non-inferiority of a preservative free formulation of Bimatoprost ophthalmic solution 0.01% (YSBP) of YS Life Science Co., Ltd. compared to LUMIGAN®…NCT07661329·Beverly Hills, California and 21 others

Enrolling by invitationA Study Evaluating the Long-Term Efficacy and Safety of Ralinepag in Subjects With PAH Via an Open-Label ExtensionStudy ROR-PH-303, ADVANCE EXTENSION, is an open-label extension (OLE) study for participants with WHO Group 1 PAH who have participated in another Phase 2 or Phase 3 study of…NCT03683186·Phoenix, Arizona and 189 others

CompletedStudy of Macitentan (ACT-064992) on Morbidity and Mortality in Patients With Symptomatic Pulmonary Arterial HypertensionThe AC-055-302/SERAPHIN study will be an event-driven Phase III study, comparing two different doses of macitentan (ACT-064992) (3 and 10 mg) vs placebo in patients with…NCT00660179·Birmingham, Alabama and 152 others

TerminatedA Trial to Determine the Efficacy and Safety of Presendin in IIHIdiopathic intracranial hypertension (IIH) has significant associated morbidity and reduced quality of life.NCT05347147·Aurora, Colorado and 23 others

PreviousPage 7 of 19Next

Other Conditions in Houston

Breast Cancer Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia